Medtronic CFO Departs; Ishrak Takes Board Chair
Ticker: MDT · Form: 8-K · Filed: Jun 23, 2025 · CIK: 1613103
| Field | Detail |
|---|---|
| Company | Medtronic PLC (MDT) |
| Form Type | 8-K |
| Filed Date | Jun 23, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-departure, board-changes, compensation
TL;DR
Medtronic CFO Karen Parkhill is out, Omar Ishrak is the new Board Chair, and CEO Geoffrey Martha has a new pay deal.
AI Summary
On June 18, 2025, Medtronic plc announced the departure of its Chief Financial Officer, Karen Parkhill, effective July 19, 2025. The company also announced the election of Dr. Omar Ishrak as a Class III Director and the appointment of Dr. Ishrak as the new Chairperson of the Board of Directors. Additionally, Medtronic entered into a new compensatory arrangement with its Chief Executive Officer, Geoffrey Martha.
Why It Matters
The departure of a CFO and the appointment of a new Board Chair can signal strategic shifts or governance changes within a major medical device company like Medtronic.
Risk Assessment
Risk Level: medium — Changes in key executive positions and board leadership can introduce uncertainty regarding future strategy and financial oversight.
Key Players & Entities
- Medtronic plc (company) — Filing company
- Karen Parkhill (person) — Departing Chief Financial Officer
- July 19, 2025 (date) — Effective date of CFO departure
- Dr. Omar Ishrak (person) — Elected Class III Director and new Chairperson of the Board
- Geoffrey Martha (person) — Chief Executive Officer
FAQ
Who is replacing Karen Parkhill as CFO?
The filing does not specify who will replace Karen Parkhill as CFO.
What is the effective date of Dr. Omar Ishrak's election as Director and Chairperson?
The filing indicates the election and appointment occurred on June 18, 2025, with Dr. Ishrak serving as Class III Director.
What are the details of the new compensatory arrangement for Geoffrey Martha?
The filing states that a new compensatory arrangement was entered into with Geoffrey Martha, but specific details are not provided in this summary.
What was the reason for Karen Parkhill's departure?
The filing states Karen Parkhill's departure is effective July 19, 2025, but does not provide a specific reason.
When did Medtronic plc file this 8-K?
Medtronic plc filed this 8-K on June 23, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 23, 2025 by Karen Parkhill regarding Medtronic plc (MDT).